title: Expression of miRNA-26a in platelets is associated with clopidogrel resistance following coronary stenting.
abstract: The present study aimed to evaluate the association between platelet microRNA (miRNA)-26a expression and clopidogrel resistance in patients who underwent coronary stenting. Between September 2013 and August 2014, 43 patients with coronary heart disease underwent percutaneous coronary intervention at Heibei General Hospital (Shijiazhuang, China). In the same period, 20 healthy volunteers without any history of cardiovascular disease were enrolled in the present study as the control group. Flow cytometry was used to measure the phosphorylation levels of vasodilator-stimulated phosphoprotein (VASP), and to calculate the platelet reactivity index (PRI). Low response to clopidogrel was defined as PRI ≥50% on day 7 following clopidogrel administration. Western blotting was used to measure protein expression of VASP and reverse transcription-quantitative polymerase chain reaction analysis was performed to determine the expression levels of mRNA and miRNAs. Bioinformatics tools were employed to predict that miR-26a, miR-199 and miR-23a may target VASP mRNA. The results of the present study demonstrated that the activity of platelets in patients with low or high clopidogrel response was increased, as compared with healthy subjects. No differences in platelet VASP protein expression levels were detected between patients with high clopidogrel response and healthy subjects; whereas VASP protein expression was elevated in patients with low clopidogrel response. Furthermore VASP gene transcription was maintained at low levels in healthy subjects and patients with high clopidogrel response, whereas patients with low clopidogrel response exhibited increased VASP mRNA expression levels. Platelet expression of miRNA-26a, but not miRNA-199 or miRNA-23a, was associated with high platelet reactivity. Serum miRNA-26a, miRNA-199 and miRNA-23a were not demonstrated to be involved in clopidogrel resistance. Therefore, the present study demonstrated that platelet miRNA-26a has an important role in clopidogrel resistance. Combined miRNA and VASP PRI tests may aid the early diagnosis and prediction of clopidogrel resistance.
authors.affiliation: Department of Internal Medicine, Hebei Medical University, Shijiazhuang, Hebei 050017, P.R. China; Department of Cardiology, Hebei General Hospital, Shijiazhuang, Hebei 050051, P.R. China.
authors.forename: Shuxia
authors.initials: S
authors.lastname: Chen
authors.affiliation: Department of Internal Medicine, Hebei Medical University, Shijiazhuang, Hebei 050017, P.R. China; Department of Cardiology, Hebei General Hospital, Shijiazhuang, Hebei 050051, P.R. China.
authors.forename: Xiaoyong
authors.initials: X
authors.lastname: Qi
authors.affiliation: Department of Cardiology, Hebei General Hospital, Shijiazhuang, Hebei 050051, P.R. China.
authors.forename: Hua
authors.initials: H
authors.lastname: Chen
authors.affiliation: Department of Cardiology, Hebei General Hospital, Shijiazhuang, Hebei 050051, P.R. China.
authors.forename: Mingquan
authors.initials: M
authors.lastname: Li
authors.affiliation: Department of Cardiology, Hebei General Hospital, Shijiazhuang, Hebei 050051, P.R. China.
authors.forename: Jian
authors.initials: J
authors.lastname: Gu
authors.affiliation: Department of Cardiology, Hebei General Hospital, Shijiazhuang, Hebei 050051, P.R. China.
authors.forename: Chunxia
authors.initials: C
authors.lastname: Liu
authors.affiliation: Department of Cardiology, Hebei General Hospital, Shijiazhuang, Hebei 050051, P.R. China.
authors.forename: Hua
authors.initials: H
authors.lastname: Xue
authors.affiliation: Department of Cardiology, Hebei General Hospital, Shijiazhuang, Hebei 050051, P.R. China.
authors.forename: Lili
authors.initials: L
authors.lastname: Wang
authors.affiliation: Department of Cardiology, Hebei General Hospital, Shijiazhuang, Hebei 050051, P.R. China.
authors.forename: Yanping
authors.initials: Y
authors.lastname: Geng
authors.affiliation: Department of Cardiology, Hebei General Hospital, Shijiazhuang, Hebei 050051, P.R. China.
authors.forename: Peng
authors.initials: P
authors.lastname: Qi
authors.affiliation: Department of Cardiology, Hebei General Hospital, Shijiazhuang, Hebei 050051, P.R. China.
authors.forename: Yuping
authors.initials: Y
authors.lastname: Han
keywords: clopidogrel resistance; microRNA; percutaneous coronary intervention; platelet; vasodilator-stimulated phosphoprotein